DoW Peer Reviewed Medical, Platform Clinical Translation Award

The DoW Peer Reviewed Medical, Platform Clinical Translation Award supports the translational development and/or early-phase clinical trials for broadly applicable clinical technologies that will address urgent and complex needs related to two congressionally directed FY26 PRMRP topic areas. The platform product in development should address one of the FY26 PRMRP portfolio-specific strategic goals and address the health care needs of military Service Members, Veterans and their Families. Key features of this opportunity include: • Allows for multiple Principal Investigators (PIs) with one PI identified as the Initiating PI and up to two additional PIs identified as Partnering PIs • Requires a PI-convened external advisory board with patient advocate participation • The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $30M to fund approximately two Platform Clinical Translation Award applications with total cost caps of $15M per award • The maximum period of performance is 4 years